Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion type Assertion NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_head.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion description "[According to the microarray profiles, PTP4A3/PRL-3 was upregulated in patients with poorly differentiated disease compared to patients with well-differentiated disease with hepatic backgrounds associated with hepatitis B or C. Validation analysis showed that the PTP4A3/PRL-3 mRNA and protein levels were significantly associated with poor differentiation (P<0.0001), high serum ?-fetoprotein (P<0.01), high serum protein induced by vitamin K absence/antagonist-II (PIVKA-II), and hepatic vascular invasion (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_provenance.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion evidence source_evidence_literature NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_provenance.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion SIO_000772 23064776 NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_provenance.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion wasDerivedFrom befree-20150227 NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_provenance.
- NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_assertion wasGeneratedBy ECO_0000203 NP227683.RAoclU1s3JU7NxNihTPcA4u8Kfll0tLTsrYt5MngQIrhQ130_provenance.